Literature DB >> 22851413

Complement fragment C3d is colocalized within the lipid rafts of T cells and promotes cytokine production.

O Borschukova1, Z Paz, I C Ghiran, C-C Liu, A H Kao, S Manzi, J M Ahearn, G C Tsokos.   

Abstract

UNLABELLED: The complement system plays an important role in tissue inflammation and damage in SLE patients. High levels of C3d were detected on the surface of erythrocytes and lymphocytes of SLE patients. The objective of this study was to assess the functional consequences of C3d fragments deposited on the surface membrane of SLE T cells.
METHODS: 46 SLE patients, 43 patients with other autoimmune diseases (OAD) and 33 healthy individuals (N) were enrolled in this study. T cells were isolated from peripheral blood and flow cytometry studies were conducted to assess the levels of C3d fragments, Ca++ influx responses and cytokine production. Confocal microscopy was used to study co-localized molecules. Student's t-test was performed to determine statistical significance among study groups.
RESULTS: A significant percentage of the SLE T cells were found to be positive for C3d (13.58 ± 3.92%) when compared with normal T cells (4.52 ± 2.92%) (p < 0.0000547) and T cells from patients with other autoimmune diseases (6.31 ± 4.57%) (p < 0.00513). Peak Ca++ influx responses were significantly higher in C3d- SLE T cells compared with C3d+ SLE T cells (p < 0.011). C3d+ T cells produced significantly more IL-2, IFN-gamma, IL-4 and IL-17. In contrast to the increased production of IL-2 by the C3d+ T cells, the overall SLE T cell population produced less IL-2 when compared with T cells from normal individuals or patients with other autoimmune disease. The C3d fragments were found to be localized within the lipid rafts.
CONCLUSION: C3d fragments are localized in the lipid rafts of SLE T cells and contribute to abnormal T cell function by modulating Ca++ influx responses and increased cytokine production.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22851413     DOI: 10.1177/0961203312454342

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  6 in total

1.  Immunogenetics of Lupus Erythematosus.

Authors:  Begüm Ünlü; Ümit Türsen; Navid Jabalameli; Fahimeh Abdollahimajd; Fateme Rajabi
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  SPECT/CT Imaging of Mycobacterium tuberculosis Infection with [125I]anti-C3d mAb.

Authors:  Catherine A Foss; Liudmila Kulik; Alvaro A Ordonez; Sanjay K Jain; V Michael Holers; Joshua M Thurman; Martin G Pomper
Journal:  Mol Imaging Biol       Date:  2019-06       Impact factor: 3.488

3.  Ligation of Glycophorin A Generates Reactive Oxygen Species Leading to Decreased Red Blood Cell Function.

Authors:  Joseph Khoory; Jessica Estanislau; Abdallah Elkhal; Asmae Lazaar; Mark I Melhorn; Abigail Brodsky; Ben Illigens; Itaru Hamachi; Yasutaka Kurishita; Alexander R Ivanov; Sergey Shevkoplyas; Nathan I Shapiro; Ionita C Ghiran
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

4.  Complement controls the immune synapse and tumors control complement.

Authors:  Alan Herbert
Journal:  J Immunother Cancer       Date:  2020-12       Impact factor: 13.751

5.  Reduction in erythrocyte-bound complement activation products and titres of anti-C1q antibodies associate with clinical improvement in systemic lupus erythematosus.

Authors:  Jill Buyon; Richard Furie; Chaim Putterman; Rosalind Ramsey-Goldman; Kenneth Kalunian; Derren Barken; John Conklin; Thierry Dervieux
Journal:  Lupus Sci Med       Date:  2016-09-30

Review 6.  Cell-bound complement activation products in SLE.

Authors:  Rosalind Ramsey-Goldman; Jian Li; Thierry Dervieux; Roberta Vezza Alexander
Journal:  Lupus Sci Med       Date:  2017-08-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.